Cost-Effectiveness of Saxagliptin in Type 2 Diabetes in the United States

被引：0
作者：
Bergenheim, Klas
Williams, Setareh A.
Bergeson, Joette G.
Stern, Lee
Sriprasert, Michelle
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2369-PO
引用
收藏
页码：A629 / A630
页数：2
相关论文
共 50 条
[21]   The Cost-Effectiveness of Supplemental Carnosine in Type 2 Diabetes [J].
Menon, Kirthi ;
de Courten, Barbora ;
Magliano, Dianna J. ;
Ademi, Zanfina ;
Liew, Danny ;
Zomer, Ella .
NUTRIENTS, 2022, 14 (01)
[22]   Cost-effectiveness of primary prevention of type 2 diabetes [J].
Icks, A. ;
Chernyak, N. ;
Klein, A. ;
Brinks, R. ;
Genz, J. ;
Giani, G. .
DIABETOLOGE, 2011, 7 (02) :92-98
[23]   COST-EFFECTIVENESS OF EXERCISE PROGRAMS IN TYPE 2 DIABETES [J].
Coyle, Doug ;
Coyle, Kathryn ;
Kenny, Glen P. ;
Boule, Normand G. ;
Wells, George A. ;
Fortier, Michelle ;
Reid, Robert D. ;
Phillips, Penny ;
Sigal, Ronald J. .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) :228-234
[24]   Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States [J].
Kamble, Shital ;
Schulman, Kevin A. ;
Reed, Shelby D. .
VALUE IN HEALTH, 2012, 15 (05) :632-638
[25]   Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review [J].
Bosetti, Rita ;
Tabatabai, Laila ;
Naufal, Georges ;
Menser, Terri ;
Kash, Bita .
PLOS ONE, 2021, 16 (11)
[26]   Cost-effectiveness analysis in the United States - Reply [J].
Pearson, SD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23) :2722-2723
[27]   Update on the cost-effectiveness of contraceptives in the United States [J].
Trussell, James ;
Sinai, Irit .
CONTRACEPTION, 2010, 82 (04) :391-392
[28]   Cost-Effectiveness of Hormone Therapy in the United States [J].
Lekander, Ingrid ;
Borgstrom, Fredrik ;
Strom, Oskar ;
Zethraeus, Niklas ;
Kanis, John A. .
JOURNAL OF WOMENS HEALTH, 2009, 18 (10) :1669-1677
[29]   A COST-EFFECTIVENESS ANALYSIS OF ALOGLIPTIN IN COMPARISON TO SAXAGLIPTIN [J].
Wingate, L. T. ;
Oishi, T. S. ;
Ali, Shubar N. S. .
VALUE IN HEALTH, 2015, 18 (03) :A61-A61
[30]   COST-EFFECTIVENESS ANALYSIS OF METFORMIN COMBINED WITH SAXAGLIPTIN VERSUS METFORMIN COMBINED WITH SULFONYLUREAS IN TYPE-2 DIABETES PATIENTS IN CHILE [J].
Elgart, J. ;
Caporale, J. ;
Aiello, E. C. ;
Waschbusch, M. ;
Jotimliansky, L. ;
Gagliardino, J. J. ;
Valencia, J. E. .
VALUE IN HEALTH, 2011, 14 (03) :A96-A96
12345